🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to investigate efficacy and safety o...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT00666965
Treatments Being Tested
Safety of SPM 962 in a once-daily repeated long-term treatment in Parkinson...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT01628965
Treatments Being Tested
The primary objective of this trial is to establish the maximum maintenance...
Status
Completed
Location
Multiple Locations
Start Date
2005-01
Trial ID
NCT01634243
Treatments Being Tested
The objective of this trial is to compare the effect of rotigotine (SPM 962...
Status
Completed
Location
Schwarz
Start Date
2004-11
Trial ID
NCT00243971
Treatments Being Tested
Male and female patients aged ≥ 30 years with advanced stage idiopathic Par...
Status
Completed
Location
Schwarz
Start Date
2004-03
Trial ID
NCT00244387
Treatments Being Tested
The aims of the trial are to assess the safety and the efficacy of SPM 962 ...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT01562743
Treatments Being Tested
The primary objective of this study is to investigate efficacy and safety o...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT01628848
The objective of this study is to evaluate the clinical efficacy and safety...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01084551
Treatments Being Tested
To investigate superiority of SPM 962 over placebo in early Parkinson's dis...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00537485
The primary objective of this study is to investigate safety of SPM 962 in ...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT01631812
Treatments Being Tested